Komtur Pharmaceutical USA Inc

Founded in 1996, IIJ America offers Internet backbone service s to its core users, including government offices and enterprise corporations in Japan. The company also strives to benefit customers in North America by serving a range of commercial Internet services and solutions. IIJ America was founded by Internet Initiative Japan, which provides various Internet connectivity and systems integration services in Japan and the United States. Internet Initiative Japan s Internet connectivity services include dial-up and high-speed access. The parent company s systems integration services include consulting, project planning, systems design, construction of network systems and systems outsourcing. In addition, Internet Initiative Japan offers various value-added services, such as security-related outsourcing to protect customers internal networks from unauthorized access and secure remote connections to internal networks. The parent company was founded in 1992.

Newport Hills Corp is a reputable company based in New York, NY, specializing in providing a range of professional services to its clients. With a focus on delivering quality results, the company offers tailored solutions to meet the unique needs of each individual or business. From consulting and advisory services to project management and strategic planning, Newport Hills Corp is dedicated to helping clients achieve their goals and objectives. With a team of experienced professionals, the company ensures that every client receives personalized attention and expert guidance. Generated from their business information

Yamo Pharmaceuticals, based in New York, NY, is a cutting-edge pharmaceutical company specializing in the development of L1-79, a novel therapy designed to target the core symptoms of autism. With a focus on both the central nervous system and metabolic aspects of the disorder, Yamo's treatment has shown promising results in clinical trials, demonstrating good tolerability among patients. Committed to advancing autism research, Yamo Pharmaceuticals is actively involved in future clinical studies and offers a compassionate use policy. With a dedicated team and a scientific advisory board, the company aims to provide effective solutions for patients and caregivers, addressing the challenges associated with autism.Generated from the website